AbbVie Balance Sheet Health
Financial Health criteria checks 3/6
AbbVie has a total shareholder equity of $8.0B and total debt of $74.4B, which brings its debt-to-equity ratio to 924.1%. Its total assets and total liabilities are $148.9B and $140.8B respectively. AbbVie's EBIT is $17.5B making its interest coverage ratio 10.4. It has cash and short-term investments of $18.1B.
Key information
924.1%
Debt to equity ratio
US$74.36b
Debt
| Interest coverage ratio | 10.4x |
| Cash | US$18.07b |
| Equity | US$8.05b |
| Total liabilities | US$140.83b |
| Total assets | US$148.87b |
Recent financial health updates
Recent updates
Earnings Tell The Story For AbbVie Inc. (NYSE:ABBV)
Jun 28
AbbVie: 5 Reasons That Make A Buy Case
Jun 18Looking For Both Income And Growth? 4%-Yielding AbbVie Has You Covered
May 29Here's Why AbbVie (NYSE:ABBV) Can Manage Its Debt Responsibly
May 21AbbVie's Q1: Positive Surprise
Apr 26AbbVie: Great To Be Proven Wrong - Still Not A Buy
Apr 14AbbVie: Still Fits Buffett's 10x EBT Rule Well Despite Guidance Revision
Apr 08AbbVie: Strong Cash Flow Growth Fuels Dividend Growth
Mar 08AbbVie: Things Are Getting Clearer
Feb 05AbbVie Q4 Earnings Preview: Few Clouds On Horizon Thanks To Masterful Management (Rating Upgrade)
Jan 30Financial Position Analysis
Short Term Liabilities: ABBV's short term assets ($38.9B) do not cover its short term liabilities ($41.5B).
Long Term Liabilities: ABBV's short term assets ($38.9B) do not cover its long term liabilities ($99.3B).
Debt to Equity History and Analysis
Debt Level: ABBV's net debt to equity ratio (699.5%) is considered high.
Reducing Debt: ABBV had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: ABBV's debt is well covered by operating cash flow (30.5%).
Interest Coverage: ABBV's interest payments on its debt are well covered by EBIT (10.4x coverage).